A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
ASSESSMENT OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
2022
Zenodo
Currently, the determination of predictors of an unfavorable outcome of the disease is of great relevance, since they allow a more rational approach to the selection of more adequate therapy. Systemic lupus erythematosus (SLE) is a particularly significant problem in clinical rheumatology, since the survival rate of this group of patients remains very low. Therefore, all attempts aimed at finding predictors that affect life expectancy in a given disease are of leading importance and this is of
doi:10.5281/zenodo.5992756
fatcat:aymk4zoa5vccnjvf3a3iwbg4re